Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Shares of Cronos Group Inc. (TSE:CRON – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is C$5.13.
A number of equities research analysts have weighed in on the stock. Raymond James restated a “buy” rating and issued a C$7.00 price objective (up previously from C$6.00) on shares of Cronos Group in a report on Friday, July 29th. Cowen cut their price objective on shares of Cronos Group to C$4.30 and set a “na” rating on the stock in a report on Tuesday, July 19th. Cowen cut their price objective on shares of Cronos Group from C$4.50 to C$4.30 in a report on Tuesday, July 19th. MKM Partners cut their price target on shares of Cronos Group from C$11.00 to C$10.00 in a report on Friday, August 12th. Finally, Canaccord Genuity Group upgraded shares of Cronos Group to a “buy” rating and set a C$5.00 price target on the stock in a report on Thursday, July 28th.
Cronos Group Price Performance
Shares of TSE CRON opened at C$3.91 on Friday. Cronos Group has a 1 year low of C$3.32 and a 1 year high of C$8.45. The company has a debt-to-equity ratio of 0.69, a current ratio of 26.18 and a quick ratio of 24.66. The company’s 50-day moving average is C$4.07 and its 200 day moving average is C$4.05. The stock has a market capitalization of C$1.48 billion and a P/E ratio of -4.15.
Cronos Group Company Profile
(Get Rating)
Cronos Group Inc operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets.
Read More
- 2 Regional Banks With Sector-Beating Price Performance
- MarketBeat: Week in Review 10/3-10/7
- ConAgra Brands Is A Value Pick For Income Investors
- 3 Stocks With Market-Beating Price Performance
- Lucid Motors May Test Investors’ Resolve, But Should They Sell?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Cronos Group, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Cronos Group wasn’t on the list.
While Cronos Group currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Kirk McDonald shares three stocks from different industries with different market caps and explains why each is a holding in his portfolio.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.
Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
